Patent details

Basic Information

Publication number:

EP1948608

PCT Application Number:

PCT/US/2006/043635

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068372382

PCT Publication Number:

WO/2007/056517

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-ÖÖ4-Ö(DIMETHYLAMINO)IMINOMETHYLÜBENZOYLÜAMINOÜ-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR

French Title of Invention:

SELS PHARMACEUTIQUES ET POLYMORPHES DU N-(5-CHLORO-2-PYRIDINYL)-2-ÖÖ4-Ö(DIMETHYLAMINO)IMINOMETHYLÜBENZOYLÜAMINOÜ-5-METHOXY-BENZAMIDE, UN INHIBITEUR DU FACTEUR X

German Title of Invention:

PHARMAZEUTISCHE SALZE UND POLYMORPHE AUS N-(5-CHLORO-2-PYRIDINYL)-2-ÖÖ4-Ö(DIMETHYLAMINO)IMINOMETHYLÜBENZOYLÜAMINOÜ-5-METHOXY-BENZAMID, EINEM FAKTOR-XA-HEMMER

SPC Number:

Dates

Filing date:

07/11/2006

Grant date:

14/03/2012

EP Publication Date:

14/03/2012

PCT Publication Date:

18/05/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/07/2008

EP B1 Publication Date:

14/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/11/2012

Expiration date:

07/11/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/11/2006

 

 

Name:

MILLENNIUM PHARMACEUTICALS INC.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

LANGLANDS Graeme

Address:

United Kingdom (GB)

2

Name:

KANTER James P.

Address:

United States (US)

3

Name:

GRANT Craig

Address:

United Kingdom (GB)

Priority

Priority Number:

735224 P

Priority Date:

08/11/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 213/75;

Filing date	Document type	Number of pages